ISARIC has been committed to provide a wide breadth of COVID-19 clinical research resources since the beginning of the outbreak. These resources are fully adaptable and completely free to use
The tools below aim to cover a range of tiers, suitable for different needs:
- Data collection only
- Contributing clinical data
- Research protocols
- Guidance to start your study
- ISARIC’s affiliated studies
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Visit this section to find ISARIC’s articles, studies and more.
Women under 50 and people who experienced severe disease had worse long-term outcomes following hospitalisation with COVID-19.
ISARIC, supported by the UK Coronavirus Immunology Consortium (UK-CIC), has identified new biomarkers of inflammation that both indicate the severity of COVID-19 and distinguish it from severe influenza.
The Lancet Infectious Diseases published the GloPID-R and ISARIC Long COVID Forum Working Group’ letter, describing the content and discussions of the Long COVID Forum which took place on 9-10 December 2020.